Figure 3.
Quantification of unconjugated and conjugated BAs in serum and liver was performed using UHPLC-QQQ-MS across the control, the antimony, the copper, and the SC groups. (A) Percentage of serum BAs in the control group. (B) Percentage of hepatic BAs in the control group. (C) Concentrations of unconjugated and conjugated BAs in serum. (D) Concentrations of unconjugated and conjugated BAs in liver. Data are expressed as mean ± SD for each group with n = 7. * p < 0.05, ** p < 0.01, and *** p < 0.001 indicate statistically significant differences determined by the two-tailed Student’s t test.